This session will begin with a conversation with Ranking Member, Energy and Commerce Committee, US House of Representatives, Cathy McMorris Rodgers followed by a panel discussion.

During the pandemic, in the face of cascading health and social crises, health and science leaders illuminated the path forward. Massive scientific investments led to groundbreaking advancements in vaccination and therapy. Unprecedented collaboration in the public and private sectors enabled remarkable progress across industries. Telehealth and digital tools proved the potential of technologies to respond to health challenges. But the pandemic revealed a darker side as well. Wide gaps and disparities in healthcare delivery, quality, and access led to tragic outcomes as underserved communities and under-resourced countries struggled in the pandemic's grip. Will we heed the lessons of COVID-19? To build on the successes and combat the failures, solutions will require innovation and commitment from across the health ecosystem. Our panel of experts will discuss the possibilities.

 Part 1:

• Guest Cathy McMorris Rodgers, US Representative, Washington; Ranking Member, Energy and Commerce Committee, US House of Representatives
• Moderator Mary Ellen McIntire, Staff Reporter, Roll Call

 Part 2:

• Moderator Sam Baker, Health Editor, Axios
• Speaker Amy Abernethy, former Principal Deputy Commissioner, US Food and Drug Administration
• Speaker Kelvin Baggett, Executive Vice President and Chief Impact Officer, McKesson
• Speaker Tanisha Carino, Executive Vice President and Chief Corporate Affairs Officer, Alexion Pharmaceuticals
• Speaker Gary Michelson, Founder and Co-Chair, Michelson Medical Research Foundation
• Speaker Andrew Plump, President, Research and Development, Takeda Pharmaceuticals